Please check your internet connection and try again.
# Hepamerz (ornithine aspartate)
## Overview
Hepamerz is a combination of the amino acids L-ornithine and L-aspartate. It is believed to work by stimulating the synthesis of urea and glutamine in the liver, thereby promoting the detoxification of ammonia.
## Primary Indications
* Treatment of hyperammonemia associated with liver disease, including hepatic encephalopathy.
## Adult Dosing
* **Intravenous:** Typically administered as an infusion. A common regimen is 10 grams of L-ornithine L-aspartate (equivalent to 5 grams L-ornithine and 5 grams L-aspartate) infused over 30-60 minutes, once to three times daily. The total daily dose should not exceed 30 grams. The duration of treatment depends on the severity of the condition and patient response.
* **Oral:** Typically 3-6 grams of L-ornithine L-aspartate administered orally up to three times daily. The total daily dose should not exceed 18 grams.
## Pediatric Dosing
* Dosing in pediatric patients is not well-established and should be individualized based on clinical assessment and response. Caution is advised.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is metabolized and excreted through the liver. However, close monitoring is warranted in patients with severe liver dysfunction.
## Contraindications
* Hypersensitivity to ornithine, aspartate, or any component of the formulation.
* Severe renal impairment (creatinine clearance < 25 mL/min), although this is debated and requires careful consideration.
* Lactic acidosis.
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal pain, diarrhea.
* **Less Common:** Muscle weakness, headache, dizziness, skin reactions.
* **Rare:** Renal stones (with prolonged high-dose use).
## Key Drug Interactions
* **Barbiturates:** May reduce the efficacy of Hepamerz.
* **Sulfonamides:** May potentiate the effect of sulfonamides.
* There are no other clinically significant drug interactions widely reported.
## Monitoring
* Serum ammonia levels.
* Liver function tests.
* Renal function.
* Neurological status (for signs of hepatic encephalopathy).
* Electrolytes.
## Clinical Pearls
* Hepamerz is primarily used to reduce elevated ammonia levels in patients with liver disease.
* The intravenous formulation is often used for acute management of hepatic encephalopathy, while the oral formulation can be used for maintenance.
* Ensure adequate hydration during intravenous infusion.
* Treatment effectiveness is often correlated with a reduction in serum ammonia levels and improvement in neurological symptoms.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and local protocols before administering any medication.
